Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- Check4 days agoChange DetectedUpdated revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedSite revision change: v3.4.3 was removed and v3.5.0 added.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.4.2 was applied and an older funding notice was removed; these are maintenance updates that do not change trial details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedAdded a government funding status notice and a new revision label (v3.4.1); these changes do not alter study details, results, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a glossary display option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision tag 'Revision: v3.4.0', replacing the previous QC and data labels. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.